Moraes Leonardo A, Ampomah Patrick B, Lim Lina H K
a Department of Physiology , Yong Loo Lin School of Medicine, National University of Singapore, & NUS Immunology Program, Life Sciences Institute, Centre for Life Sciences, National University of Singapore , Singapore.
Cell Adh Migr. 2018;12(5):417-423. doi: 10.1080/19336918.2018.1486143. Epub 2018 Aug 19.
Targeting inflammation in cancer has shown promise to improve and complement current therapies. The tumor microenvironment plays an important role in cancer growth and metastasis and -tumor associated macrophages possess pro-tumoral and pro-metastatic properties. Annexin A1 (ANXA1) is an immune-modulating protein with diverse functions in the immune system and in cancer. In breast cancer, high ANXA1 expression leads to poor prognosis and increased metastasis. Here, we will review ANXA1 as a modulator of inflammation, and discuss its importance in breast cancer and highlight its new role in alternative macrophage activation in the tumor microenvironment. This review may provide an updated understanding into the various roles of ANXA1 which may enable future therapeutic developments for the treatment of breast cancer.
针对癌症中的炎症进行治疗已显示出有望改善和补充当前疗法。肿瘤微环境在癌症的生长和转移中起着重要作用,肿瘤相关巨噬细胞具有促肿瘤和促转移特性。膜联蛋白A1(ANXA1)是一种免疫调节蛋白,在免疫系统和癌症中具有多种功能。在乳腺癌中,高ANXA1表达会导致预后不良和转移增加。在此,我们将综述ANXA1作为炎症调节剂的作用,并讨论其在乳腺癌中的重要性,突出其在肿瘤微环境中替代巨噬细胞活化方面的新作用。本综述可能会提供对ANXA1各种作用的最新认识,这可能有助于未来乳腺癌治疗的新疗法开发。